Nevro on May 15 achieved CE mark approval for its Senza Omnia spinal cord stimulation system, Medical Device-Network reports.
Four things to know:
1. Senza Omnia delivers Nevro's HF10 therapy as well as other spinal cord stimulation frequencies.
2. The device is equipped with a programmer that facilitates more waveforms across the spinal cord frequency spectrum.
3. Senza Omnia also features a redesigned patient remote that aims to improve the patient experience.
4. Nevro achieved FDA clearance for the SCS system in November.